The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease
- PMID: 14623701
- DOI: 10.1001/archderm.139.11.1417
The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease
Abstract
Objectives: Clinical scores used to assess the severity of atopic dermatitis (AD) rely entirely on subjective criteria to evaluate the severity of lesions and the extent of involvement. The aim of this study was to develop an objective measure of AD severity by measuring stratum corneum (SC) functions and by using computer-assisted estimates of involved body surface areas (BSAs).
Design: Barrier function of the SC was assessed by measuring transepidermal water loss, and SC hydration was assessed by measuring capacitance. The extent of disease was assessed using a computer-assisted algorithm.
Patients: A total of 38 sequential volunteers aged 4 months to 18 years (25 girls, 13 boys) with mild to severe AD at a university outpatient pediatric dermatology clinic.
Main outcome measures: The computer-assisted method for estimating BSA was compared with estimates using the "rule of nines." The Objective Severity Assessment of Atopic Dermatitis (OSAAD) score, derived from measurements of SC barrier function and SC hydration and normalized for extent of disease was compared with the Scoring Atopic Dermatitis (SCORAD) index.
Results: Measurements of epidermal permeability barrier function and SC hydration correlated with clinical estimates of disease severity. The computer-assisted measurements of the extent of disease correlated with estimates derived from the rule of nines. The OSAAD scores correlated with the currently used instrument for AD severity, the SCORAD index.
Conclusion: The OSAAD is a new AD severity score that avoids the pitfalls of currently used subjective scoring systems by using objective measures.
Comment in
-
"Objective" measures of atopic dermatitis severity: in search of the holy Grail.Arch Dermatol. 2003 Nov;139(11):1490-2. doi: 10.1001/archderm.139.11.1490. Arch Dermatol. 2003. PMID: 14623711 No abstract available.
Similar articles
-
The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis.Br J Dermatol. 2005 Oct;153(4):767-73. doi: 10.1111/j.1365-2133.2005.06697.x. Br J Dermatol. 2005. PMID: 16181458
-
Instrumental assessment of atopic eczema: validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema.J Am Acad Dermatol. 2006 Nov;55(5):772-80. doi: 10.1016/j.jaad.2006.03.036. Epub 2006 Jun 13. J Am Acad Dermatol. 2006. PMID: 17052481
-
Assessment of atopic eczema: clinical scoring and noninvasive measurements.Br J Dermatol. 2007 Oct;157(4):674-80. doi: 10.1111/j.1365-2133.2007.08101.x. Epub 2007 Aug 2. Br J Dermatol. 2007. PMID: 17672874
-
Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score.Br J Dermatol. 2007 Oct;157(4):645-8. doi: 10.1111/j.1365-2133.2007.08112.x. Epub 2007 Aug 21. Br J Dermatol. 2007. PMID: 17714568 Review.
-
Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products.J Cosmet Dermatol. 2006 Jun;5(2):140-9. doi: 10.1111/j.1473-2165.2006.00241.x. J Cosmet Dermatol. 2006. PMID: 17173589 Review.
Cited by
-
Biophysical Measurements and Ultrasonographic Findings in Chronic Dermatitis in Comparison with Uninvolved Skin.Indian J Dermatol. 2019 Mar-Apr;64(2):90-96. doi: 10.4103/ijd.IJD_464_17. Indian J Dermatol. 2019. PMID: 30983602 Free PMC article.
-
Characterizing stratum corneum structure, barrier function, and chemical content of human skin with coherent Raman scattering imaging.Biomed Opt Express. 2018 Nov 26;9(12):6425-6443. doi: 10.1364/BOE.9.006425. eCollection 2018 Dec 1. Biomed Opt Express. 2018. PMID: 31065440 Free PMC article.
-
Therapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis.Ann Dermatol. 2010 Aug;22(3):245-54. doi: 10.5021/ad.2010.22.3.245. Epub 2010 Aug 5. Ann Dermatol. 2010. PMID: 20711259 Free PMC article.
-
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.Curr Opin Allergy Clin Immunol. 2009 Oct;9(5):437-46. doi: 10.1097/ACI.0b013e32832e7d36. Curr Opin Allergy Clin Immunol. 2009. PMID: 19550302 Free PMC article. Review.
-
Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.J Invest Dermatol. 2011 Sep;131(9):1845-52. doi: 10.1038/jid.2011.144. Epub 2011 Jun 2. J Invest Dermatol. 2011. PMID: 21633371 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources